| | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2023 ( Subtotal = $0 ) |
| 2023 | 2018 | SIGNALRX PHARMACEUTICALS, INC. | 2215 PILGRIM MILL CIR | CUMMING | GA | 30041 | FORSYTH | USA | Cancer Treatment Research | 000 | 1 | 6/13/2023 | NEW | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $0 ) |
| 2021 | 2018 | SIGNALRX PHARMACEUTICALS, INC. | 2215 PILGRIM MILL CIR | CUMMING | GA | 30041 | FORSYTH | USA | Cancer Treatment Research | 000 | 1 | 9/24/2021 | NEW | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $0 ) |
| 2020 | 2018 | SIGNALRX PHARMACEUTICALS, INC. | 12545 EL CAMINO REAL UNIT C | SAN DIEGO | CA | 92130 | SAN DIEGO | USA | Cancer Treatment Research | 000 | 1 | 6/29/2020 | NEW | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $299,738 ) |
| 2018 | 2018 | SIGNALRX PHARMACEUTICALS, INC. | 12545 EL CAMINO REAL | SAN DIEGO | CA | 92130 | SAN DIEGO | USA | Cancer Treatment Research | 000 | 1 | 8/20/2018 | NEW | $299,738 |
|
|